Response to Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital

被引：0
|
作者：
Patel, Devin N. [1 ]
Chapin, Brian F. [2 ]
Freedland, Stephen J. [1 ,3 ]
机构：
[1] Cedars Sinai Med Ctr, Div Urol, Los Angeles, CA 90048 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[3] Vet Affairs Med Ctr, Div Urol, Durham, NC 27705 USA
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2018年 / 25卷 / 12期
关键词：
D O I：
10.1111/iju.13861
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1005 / 1005
页数：1
相关论文
共 50 条
  • [1] Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital
    Poelaert, Filip
    Schatteman, Peter
    Lumen, Nicolaas
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (12) : 1004 - 1004
  • [2] Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital
    Patel, Devin N.
    Jha, Shalini
    Howard, Lauren E.
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Terris, Martha K.
    Chapin, Brian F.
    Freedland, Stephen J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (12) : 998 - 1004
  • [3] THE IMPACT OF PRIOR LOCAL THERAPY ON OVERALL SURVIVAL IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM SEARCH
    Patel, Devin
    Jha, Shalini
    Howard, Lauren
    Amling, Christopher
    Aronson, William
    Cooperberg, Matthew
    Kane, Christopher
    Terris, Martha
    Chapin, Brian
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E229 - E230
  • [4] Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database
    Hanyok, Brian T.
    Howard, Lauren E.
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Terris, Martha K.
    Posadas, Edwin M.
    Freedland, Stephen J.
    CANCER, 2016, 122 (02) : 222 - 229
  • [5] Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
    Tablazon, Ingrid Lorese
    Howard, Lauren E.
    De Hoedt, Amanda M.
    Aronson, William J.
    Kane, Christopher J.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Terris, Martha K.
    Freedland, Stephen J.
    Williams, Stephen B.
    CANCER, 2019, 125 (22) : 4003 - 4010
  • [6] Editorial Comment to Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer
    Yamamoto, Yoshiyuki
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (07) : 831 - 832
  • [7] Prognostic impact of prior local therapy in castration-resistant prostate cancer
    Koura, Mikifumi
    Shiota, Masaki
    Ueda, Shohei
    Matsumoto, Takashi
    Kobayashi, Satoshi
    Monji, Keisuke
    Kashiwagi, Eiji
    Takeuchi, Ario
    Inokuchi, Junichi
    Shiga, Ken-ichiro
    Yokomizo, Akira
    Eto, Masatoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (07) : 1142 - 1148
  • [8] Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel
    Une, Minami
    Takemura, Kosuke
    Inamura, Kentaro
    Fukushima, Hiroshi
    Ito, Masaya
    Kobayashi, Shuichiro
    Yuasa, Takeshi
    Yonese, Junji
    Board, Philip G.
    Koga, Fumitaka
    CANCERS, 2021, 13 (21)
  • [9] Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    dos Reis, Rodolfo Borges
    Muglia, Valdair
    Faria, Eliney F.
    INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 612 - 613
  • [10] Predictors of overall survival in patients with metastatic castration-resistant prostate cancer
    Markova, A. S.
    Polikarpova, S. B.
    Kamolov, B. Sh.
    Gridneva, Ya. V.
    Kalinin, S. A.
    Peters, M. V.
    Matveev, V. B.
    ONKOUROLOGIYA, 2015, 11 (02): : 77 - 84
12345